Dürr Aktiengesellschaft Earnings Call Transcripts
Fiscal Year 2025
-
Group streamlined to three divisions, sold environmental tech business, and improved EBIT margin to 5.6%. Despite sales challenges, net profit doubled to EUR 206 million, and free cash flow exceeded expectations. 2026 outlook is cautious due to macro uncertainty.
-
Q3 saw a strong EBIT margin and robust free cash flow, with all divisions contributing to earnings growth. The group completed its transformation by selling Environmental Technology, expects to meet guidance at the lower end of the sales range, and will use sale proceeds to reduce debt.
-
Q2 saw weak order intake and a major impairment due to geopolitical and e-mobility headwinds, but strong cash flow and a significant book gain from the environmental tech sale offset restructuring costs. The group remains focused on automation, cost savings, and maintaining profitability targets.
-
Order intake and sales remained robust in Q1 2025, with net income up 40% year-over-year and positive free cash flow. Guidance for 2025 is confirmed despite tariff uncertainties, and the sale of the environmental business is on track.
Fiscal Year 2024
-
Record order intake and revenues in 2024 were driven by strong automotive demand and operational improvements, with EBIT margin near the upper end of guidance. 2025 guidance anticipates stable to moderate growth, margin improvement, and continued portfolio streamlining, with a focus on automation and sustainability.
-
Record order intake and strong free cash flow were driven by robust automotive demand and disciplined working capital, offsetting weakness at HOMAG and delays in some projects. Guidance for 2024 is confirmed at the upper end for order intake and cash flow, with segment performance mixed across divisions.
-
Record H1 order intake and solid sales growth were driven by strong automotive demand and large global orders. EBIT margin improved, free cash flow was robust, and 2024 guidance was confirmed, with the outlook favoring the upper end of order intake targets.